Guaifenesin (Glyceryl Guaiacolate)
A to Z Drug Facts
Guaifenesin (Glyceryl Guaiacolate) |
(GWHY-fen-ah-sin) |
Anti-Tuss |
Syrup |
100 mg/5 mL |
Breonesin |
Capsules |
200 mg |
Diabetic Tussin EX |
Liquid |
100 mg/5 mL |
Duratuss-G |
Tablets |
1200 mg |
Fenesin |
Tablets, sustained release |
600 mg |
Gee-Gee |
Tablets |
200 mg |
Genatuss |
Syrup |
100 mg/5 mL |
GG-Cen |
Capsules |
200 mg |
Glyate |
Syrup |
100 mg/5 mL |
Glycotuss |
Tablets |
100 mg |
Glytuss |
Tablets |
200 mg |
GuiaCough CF |
Liquid |
12.5 mg |
GuiaCough PE |
Liquid |
100 mg |
Guiafenex LA |
Tablets, extended release |
600 mg |
Guiatuss |
Syrup |
100 mg/5 mL |
Humibid LA |
Tablets, sustained release |
600 mg |
Humibid Sprinkle |
Capsules, sustained release |
300 mg |
Hytuss |
Tablets |
100 mg |
Hytuss 2x |
Capsules |
200 mg |
Liquibid |
Tablets, sustained release |
600 mg |
Monafed |
Tablets, sustained release |
600 mg |
Muco-Fen-LA |
Tablets, sustained release |
600 mg |
Mytussin |
Syrup |
100 mg/5 mL |
Naldecon Senior EX |
Liquid |
200 mg/5 mL |
Organidin NR |
Tablets |
200 mg |
Liquid |
100 mg/5 mL |
Pneumomist |
Tablets, sustained release |
600 mg |
Respa-GF |
Tablets, sustained release |
600 mg |
Robitussin |
Syrup |
100 mg/5 mL |
Scot-tussin Expectorant |
Syrup |
100 mg/5 mL |
Sinumist-SR Capsulets |
Tablets, sustained release |
600 mg |
Siltussin SA |
Syrup |
100 mg/5 mL |
Touro Ex |
Caplets, sustained release |
600 mg |
Tussin |
Syrup |
100 mg/5 mL |
Tusibron |
Syrup |
100 mg/5 mL |
Uni-tussin |
Syrup |
100 mg/5 mL |
alminil Expectorant |
Benylin E |
Class: Expectorant |
Action May enhance output of respiratory tract fluid by reducing adhesiveness and surface tension, thus facilitating removal of viscous mucus and making nonproductive coughs more productive and less frequent. Efficacy not well documented.
Indications Temporary relief of cough associated with respiratory tract infections and related conditions such as sinusitis, pharyngitis, bronchitis, and asthma when these conditions are complicated by tenacious mucus or mucus plugs and congestion; effective for productive as well as nonproductive cough, particularly dry, nonproductive cough that tends to injure mucous membranes of the air passages.
Contraindications Standard considerations.
Immediate-release Adults and Children (at least 12 yr): PO 200 to 400 mg q 4 hr (max, 2.4 g/day).
Children (6 to 12 yr): PO 100 to 200 mg q4 hr (max, 1.2 g/day).
Children (2 to 6 yr): PO 50 to 100 mg q 4 hr (max, 600 mg/day).
Children (6 mo to under 2 yr): PO Individualize dose, 25 to 50 mg q 4 hr (max, 300 mg/day).
Sustained- or Extended-release Adults and children (at least 12 yr): PO 575 mg to 1.2 g q 12 hr (max, 2.4 g/day).
Children (6 to 12 yr): PO 575 to 600 mg q 12 hr (max, 1.2 g/day).
Children (2 to 6 yr): PO 275.5 to 300 mg q 12 hr (max, 600 mg/day).
None well documented.
Lab Test Interferences May cause color interference with certain laboratory determinations of 5-hydroxyindoleacetic acid and vanillylmandelic acid. Discontinue use 48 hr before test.
CNS: Dizziness; headache. DERMATOLOGIC: Rash; urticaria. GI: Nausea; vomiting.
Pregnancy: Category C. Lactation: Undetermined. Persistent cough: May indicate serious condition. Notify physician, pharmacist, or nurse if cough persists for more than 1 wk, tends to recur or is accompanied by high fever, rash, or persistent headache.
PATIENT CARE CONSIDERATIONS |
|
Books@Ovid
Copyright © 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts